D
Mirum Pharmaceuticals, Inc. MIRM
$72.66 $0.851.18% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 76.21% 41.94% 33.28% 39.65% 66.72%
Total Depreciation and Amortization 3.45% 6.85% 21.20% 127.46% 338.17%
Total Amortization of Deferred Charges 4.91% 4.59% 4.26% 3.16% 32.57%
Total Other Non-Cash Items 38.14% 67.40% -37.03% 5.91% -77.78%
Change in Net Operating Assets -519.45% -147.18% 77.41% 159.08% 144.66%
Cash from Operations 416.59% -112.89% 69.50% 121.86% 78.06%
Capital Expenditure 83.83% -215.38% -- -- -1,045.59%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 91.00% -- 133.05% -159.52% -242.13%
Cash from Investing 90.93% -124,007.69% 132.05% 90.13% -243.86%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 19.16% 427.72% 159.48% -98.13% 247.69%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 19.16% 427.72% 200.51% -98.13% -93.64%
Foreign Exchange rate Adjustments 1,970.59% 833.63% -1,376.85% 127.94% -4.39%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 123.58% -164.67% 97.22% -273.23% -146.92%